-
February 1, 2012
Breast cancer charity ends Planned Parenthood funding
The Komen Foundation, best-known for the Race for the Cure fundraisers it sponsors around the country each year, did not immediately respond to a request for comment from Reuters.
-
December 30, 2011
Yoga helps breast cancer survivors curb fatigue
NEW YORK (Reuters Health) - About one third of breast cancer survivors experience fatigue that can affect their quality of life, but a small new study finds that doing yoga might help restore some lost vitality.
-
October 26, 2011
Doctors split on Avastin for breast cancer: survey
NEW YORK (Reuters Health) - An international survey of cancer doctors shows many question U.S. health advisers' 2010 rejection of Roche's drug Avastin to treat advanced breast cancer.
-
October 20, 2011
More breast cancer diagnosed in women with diabetes
NEW YORK (Reuters Health) - Women with recently diagnosed diabetes may be more likely to also get a breast cancer diagnosis than those without diabetes, suggests a new study from Canada.
-
October 18, 2011
Male breast cancer rare, but can be aggressive
NEW YORK (Reuters Health) - Men get diagnosed with breast cancer at less than one percent the rate of women, according to a new analysis of cancer rates from six cities and countries.
-
October 7, 2011
Antioxidants tied to mixed effects in breast cancer
NEW YORK (Reuters Health) - Breast cancer patients who take antioxidants may have an increased or decreased risk of death or recurrent cancer, depending on which vitamin they use, a new study suggests.
-
October 6, 2011
CORRECTION: Early breast cancer screening may help some: study
NEW YORK (Reuters Health) - Starting breast cancer screening as early as age 25 may help women who carry a genetic mutation linked to a higher risk of cancer live longer, suggests a new study.
-
October 6, 2011
Breast cancer drug tied to diabetes in older women
NEW YORK (Reuters Health) - Older women taking the breast cancer drug tamoxifen may have an increased risk of developing diabetes, a new study suggests.
-
October 5, 2011
Early breast cancer screening may help some: study
NEW YORK (Reuters Health) - Starting breast cancer screening as early as age 25 may help women who carry a genetic mutation linked to a higher risk of cancer live longer, suggests a new study.
-
October 3, 2011
Calif. insurer won't pay for breast cancer drug
-
September 26, 2011
Breast cancer study shows benefits of double therapy
STOCKHOLM (Reuters) - Giving breast cancer patients radiotherapy and chemotherapy at the same time significantly cuts the risk their tumors will come back and should be considered as a new treatment approach across the world, cancer experts said on Sunday.
-
September 26, 2011
Novartis's Afinitor shows promise in breast cancer
STOCKHOLM (Reuters) - Combining two drugs from Novartis and Pfizer to treat post-menopausal women with a certain type of advanced breast cancer more than doubled the time they lived without their disease getting worse, study data showed on Monday.
-
September 19, 2011
Poor women get more unneeded breast cancer surgery
NEW YORK (Reuters Health) - Old, poor and Hispanic women are all more likely to have lymph nodes under the armpit removed unnecessarily during breast cancer surgery, a new study finds.
-
September 8, 2011
NBC reporter Andrea Mitchell has breast cancer
WASHINGTON (Reuters) - Andrea Mitchell, NBC's chief foreign affairs correspondent and wife of former Federal Reserve Chairman Alan Greenspan, said on her TV program on Wednesday that she has breast cancer.
-
September 7, 2011
Plant-rich diets tied to lower breast cancer risk
NEW YORK (Reuters Health) - Women with diets rich in vegetables, fruit and legumes may have a somewhat decreased risk of developing one type of breast cancer, a new study suggests.
-
August 29, 2011
New breast cancer gene may help predict risk
NEW YORK (Reuters Health) - Screening for mutations in a gene known as CHEK2 may help determine a woman's odds of breast cancer if the disease runs in her family, Polish scientists suggested Monday.
-
July 29, 2011
REFILE: Myriad can patent breast cancer genes: court
CHICAGO (Reuters) - A U.S. federal appeals court affirmed the right of Myriad Genetics to patent two genes linked to breast cancer, overturning a lower court ruling that threatened a key element of the biotech business.
-
July 29, 2011
Screening has little impact on breast cancer deaths
LONDON (Reuters) - Falling breast cancer death rates have little to do with breast screening but are down to better treatment and health systems, scientists said on Friday, in a study likely to fuel a long-running row over the merits of mammograms.
-
July 28, 2011
Women who eat lots of fiber have less breast cancer
NEW YORK (Reuters Health) - A fresh look at the medical evidence shows women who eat more fiber are less likely to get breast cancer.
-
July 25, 2011
Breast cancer more lethal in blacks, reason unknown
NEW YORK (Reuters Health) - It is still a mystery why black women are more likely to die from breast cancer than whites, according to a new study that shows the racial disparity can't be chalked up to obesity differences.
-
July 15, 2011
Roche's pertuzumab helps breast cancer patients
ZURICH (Reuters) - Patients with advanced breast cancer lived significantly longer without their disease getting worse when treated with Roche's pertuzumab and Herceptin along with a type of chemotherapy, a late-stage study showed.
-
June 29, 2011
US FDA panel rejects Avastin for breast cancer use
SILVER SPRING, Md. (Reuters) - U.S. health advisers delivered a blow to Roche Holding on Wednesday, voting to reject the use of Roche Holding drug Avastin for breast cancer while the Swiss drugmaker conducts more studies.
-
June 28, 2011
New York sues breast cancer charity over donations
NEW YORK (Reuters) - The state of New York sued a breast cancer charity Tuesday, accusing it of soliciting more than $9 million and spending virtually none of it on the cause.
-
June 28, 2011
U.S. hears Roche on Avastin for breast cancer
SILVER SPRING, Md. (Reuters) - Breast cancer patients testified that Roche Holding AG's drug Avastin saved their lives as U.S. health officials consider whether the world's best-selling cancer drug should still be approved for that condition.
-
May 31, 2011
Beta-blockers tied to breast cancer survival
NEW YORK (Reuters Health) - Women with breast cancer who take common blood pressure drugs may have better odds of surviving the disease, according to two preliminary studies.
-
May 27, 2011
New breast cancer guidelines 'unsafe': women
NEW YORK (Reuters Health) - More than eight out of 10 women say new guidelines recommending against routine breast cancer screening of women under 50 are "unsafe," according to a small survey.
-
May 25, 2011
Short wait for breast cancer surgery seems safe
NEW YORK (Reuters Health) - Women newly diagnosed with earlier-stage breast cancer can take a few weeks to prepare for surgery without raising the odds that their tumor will progress, a new study suggests.
-
April 15, 2011
EU body relaxes curb on Avastin breast cancer use
LONDON (Reuters) - European regulators said on Friday they were relaxing curbs on the use of Roche's top-selling cancer drug Avastin to allow its use with Xeloda, another type of chemotherapy that is also made by Roche.
-
March 25, 2011
Five years on breast cancer drug tamoxifen beats two
NEW YORK (Reuters Health) - A new study has a bit of good news for most women who've had breast cancer surgery.
-
March 22, 2011
Heart drug linked to higher breast cancer risk
NEW YORK (Reuters Health) - Women taking the heart drug digoxin have an increased risk of breast cancer, according to a study of more than 2 million Danes.
-
March 21, 2011
Long-term tamoxifen boosts breast cancer survival
LONDON (Reuters) - Breast cancer patients who take the generic drug tamoxifen for five years are less likely to see their cancer return than those who take it for only two years, according to a large long-term study by British scientists.
-
March 14, 2011
Breast cancer may not change lifespan for older women
NEW YORK (Reuters Health) - Older women who are diagnosed with early-stage breast cancer can expect to live just as long as peers without breast cancer, according to a new study.
-
March 2, 2011
CORRECTION: Being too fat raises risk of deadly breast cancer
CHICAGO (Reuters) - Scientists know that being overweight increases the risk of breast cancers fed by estrogen, but being too fat may also increase the risk of triple-negative breast cancers, a less common and far more deadly type, U.S. researchers said on Tuesday.
-
March 2, 2011
Being too fat raises risk of deadly breast cancer
CHICAGO (Reuters) - Scientists know that being overweight increases the risk of breast cancers fed by estrogen, but being too fat may also increase the risk of triple-negative breast cancers, a less common and far more deadly type, U.S. researchers said on Tuesday.
-
March 1, 2011
U.S. breast cancer rates have stopped falling
CHICAGO (Reuters) - Breast cancer rates among U.S. white women have stopped falling, U.S. researchers said on Monday, suggesting that the fallout from a 2002 study linking hormone replacement therapy to breast cancer was short lived.
-
February 22, 2011
Breast cancer screening less accurate in survivors
NEW YORK (Reuters Health) - Screening mammography is less accurate at spotting breast cancer if a woman has had the disease before, according to a new government-funded study.
-
February 9, 2011
Lymph node removal unneeded for some breast cancer
CHICAGO (Reuters) - Women with early breast cancer may not need to have surgery to remove cancerous lymph nodes under the armpit, U.S. researchers said on Tuesday.
-
January 31, 2011
Starting HRT early raises breast cancer risk: study
WASHINGTON (Reuters) - Women who start hormone replacement therapy (HRT) as they begin to go through menopause have a higher risk of breast cancer than women who start taking the drugs later, researchers reported on Friday.
-
January 4, 2011
Avastin raises heart failure risk in breast cancer
CHICAGO (Reuters) - Women with advanced breast cancer who were treated with Roche's Avastin were more likely to develop heart failure than other women, according to an analysis released on Tuesday that raised more concerns about the already troubled drug.
-
December 30, 2010
Family history not the sole risk for breast cancer
NEW YORK (Reuters Health) - A new study reconfirms something often forgotten by women and sometimes even by doctors: just because breast cancer has not struck a family before does not mean family members are safe from the disease.
-
December 16, 2010
U.S., EU curb Roche's Avastin for breast cancer
WASHINGTON/LONDON (Reuters) - Roche's top drug Avastin should no longer be approved for breast cancer, U.S. regulators said on Thursday, in an unusual move that could shave $1 billion from its annual sales.
-
December 15, 2010
CORRECTION: Can depression influence breast cancer survival?
NEW YORK (Reuters Health) - A diagnosis of breast cancer will inevitably sink a woman's mood, but those whose spirits lift over time appear to survive longer, a new study suggests.
-
December 10, 2010
Popular new breast cancer treatment lacks data
NEW YORK (Reuters Health) - A new radiation treatment for breast cancer is becoming increasingly popular despite lack of good evidence, at least among well-insured Medicare patients, U.S. researchers say,.
-
December 9, 2010
Zometa fails to help breast cancer survival: study
NEW YORK (Reuters) - The Novartis osteoporosis drug Zometa failed to improve disease free survival of early breast cancer patients in a large clinical trial, but some benefit was observed in older patients who took the medicine, researchers said.
-
November 12, 2010
No link found between iron and breast cancer
NEW YORK (Reuters Health) - While some prior research has hinted at a link between meat consumption and breast cancer, a large new study suggests that the iron in meat is probably not to blame.
-
October 27, 2010
Brisk walkers have lower breast cancer risk
NEW YORK (Reuters Health) - Women who take brisk walks regularly have a lower risk of developing breast cancer after menopause -- and it's never too late to start, new study findings suggest.
-
October 21, 2010
Collards and carrots may ward off breast cancer
NEW YORK (Reuters Health) - Eating lots of carrots and cruciferous vegetables -- collard greens, cabbage, broccoli -- could reduce breast cancer risk, particularly an aggressive form common among African American women, suggests a large new study.
-
October 19, 2010
Hormone therapy raises breast cancer deaths -study
CHICAGO (Reuters) - Women who took hormone replacement pills had more advanced breast cancers and were more likely to die from them than women who took a dummy pill, raising new concerns about the commonly prescribed drugs, U.S. researchers said on Tuesday.
-
October 18, 2010
More support for soy after breast cancer
NEW YORK (Reuters Health) - More evidence suggests eating soy may pose a slight benefit to some women who have been diagnosed with breast cancer, but it's too early to recommend cancer survivors change their diets, some experts say.
-
October 11, 2010
Erbitux may help fight breast cancer, claims study
MILAN (Reuters) - An established targeted therapy for bowel cancer may also help women with an aggressive form of breast cancer, a mid-stage clinical study revealed on Monday, opening up a potential new market for the medicine.